Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the ...
Dr Beáta Halassy, a scientist working in a laboratory at the University of Zagreb, experienced a recurrence of breast cancer ...
A deep learning AI model developed by researchers significantly accelerates the detection of pathology in animal and human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback